You are here

Article Text

Article menu
Download PDFPDF
Letter
IGRA for children in the UK: patchy availability, problems with funding, lack of clarity about its role
  1. O M Etuwewe,
  2. A Riordan
  1. Department of Paediatric Infectious Diseases and Immunology. Royal Liverpool Children’s Hospital NHS Trust
  1. Onajite M Etuwewe, Paediatrics, Dept of Paediatric Infectious Diseases and Immunology. Royal Liverpool Children’s Hospital NHS Trust; onajite.etuwewe{at}nhs.net

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We were interested to read the study by Taylor et al of interferon gamma release assays (IGRA) in paediatric tuberculosis (TB).1 The authors highlight reliance on IGRA within NICE guidelines but advise caution when interpreting results.

    We surveyed paediatricians who manage TB in January 2008, asking …

    View Full Text

    Footnotes

    • Competing interests: None.